Health Condition 1: L400- Psoriasis vulgaris
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
IADVL Academy
Eligibility
Inclusion criteria
Inclusion criteria: Newly diagnosed cases of Psoriasis of both genders.
Exclusion criteria
Exclusion criteria: Patients suffering from psoriatic erythroderma. Patients with diseases that can cause secondary hyperlipidemia such as hypothyroidism, diabetes mellitus, nephrotic syndrome, chronic renal insufficiency, obstructive liver disease and connective tissue disorder. Patients on medications such as corticosteroids, retinoids, cyclosporin and lipid lowering agents will be excluded.Patients with diseases that can cause secondary hypolipidemia and hypoproteinemia such as malnutrition, liver failure, malabsorption syndromes, and hyperthyroidism will be excluded. Patients with diseases that can cause secondary hyperproteinemia will also be excluded. Patients who are unwilling to give consent to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atherogenic Index vs Cardiovascular Risk -0.3 – 0.1Low Risk 0.1 – 0.24Medium Risk 0.24 High Risk Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| ATHEROGENIC COEFFICIENT: ((Total Cholesterol-Serum HDL-c))/(HDL-c)Timepoint: Baseline;CASTELLI RISK INDEX 1: (Total Cholesterol(TC))/(HDL-c)Timepoint: Baseline;CASTELLI RISK INDEX 2: (LDL-c)/(HDL-c)Timepoint: Baseline;COMPREHENSIVE LIPID TETRAD INDEX: [total cholesterol × triglycerides × lipoprotein (a)]/high-density lipoproteinTimepoint: Baseline;FRAMINGHAM RISK SCORETimepoint: Baseline;LAP : WC-58 × TG for women LAP : WC-65 × TG for menTimepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr. Aditya Jaidka
Dr B R Ambedkar Medical College and Hospital, Bangalore
Outcome results
None listed